Akari Therapeutics Plc (AKTX)
0.2675
+0.01
(+2.29%)
USD |
NASDAQ |
Dec 30, 16:00
0.2378
-0.03
(-11.10%)
Pre-Market: 08:08
Akari Therapeutics EPS Diluted (Quarterly): -0.1948 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.207 |
| Ascendis Pharma A/S | -1.173 |
| Cellectis SA | 0.0058 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.362M |
| Total Expenses (Quarterly) | 6.362M |
| Enterprise Value | 9.133M |
| Earnings Yield | -146.3% |